BULL-CERTIFICATE STOP LOSS - RECORDATI INDUSTRIA CHIMICA E FARMA BULL-CERTIFICATE STOP LOSS - RECORDATI INDUSTRIA CHIMICA E FARMA Share Price
Certificat
P1FSG9
NLBNPIT1FSG9
| Market Closed - Borsa Italiana 01:34:59 20/06/2024 am IST | ||
| 16.4 EUR | -3.59% |
|
| Current month | -5.64% | ||
| 1 month | -15.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 19/24/19 | 16.4 | -3.59% |
| 18/24/18 | 17.01 | +5.59% |
| 17/24/17 | 16.11 | -3.30% |
| 14/24/14 | 16.66 | -4.69% |
| 13/24/13 | 17.48 | -2.24% |
Real-time Borsa Italiana
Last update June 20, 2024 at 01:34 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1FSG9 | |
| ISIN | NLBNPIT1FSG9 |
| Date issued | 05/08/2022 |
| Strike | 31.64 € |
| Maturity | 19/12/2025 (548 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.92 € |
|---|---|
| Lowest since issue | 5.48 € |
| Spread | 0.6 € |
| Spread % | 3.59% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
47.84
EUR
Average target price
52.64
EUR
Spread / Average Target
+10.03%
- Stock Market
- Certificates
- P1FSG9 Certificat
